METHOD FOR TREATING PATIENTS WITH UROGENITAL HERPES-VIRAL INFECTION IN COMBINATION WITH CHLAMYDIOSIS Russian patent published in 2006 - IPC A61K35/60 A61N5/67 

FIELD: medicine, dermatovenerology.

SUBSTANCE: on establishing the diagnosis at the first stage of therapy it is necessary to prescribe derinate as 1.5%-solution per 5.0 ml intramuscularly 5 times every 48 h followed by magneto-infrared-laser impact: wave length being 0.85-0.95 mcm, impulse frequency being 50 Hz, power of light diodes radiation being 50 mW, magnetic induction corresponds to about 20-80 mTl, dosage of energetic impact ranges 0.8-1.07 J/sq. cm. Total time for procedure - 10 min. One should affect the area of thymus gland for 2 min, spleen - 2 min, inguinal lymph nodes - per 2 min, lumbosacral - 2 min. Therapy course consists of 10 daily procedures. The innovation enables to shorten therapy terms, improve quality of life in patients with urogenital herpes-viral infection in combination with chlamydiosis and increase the number of medicinal preparations for treating the above-mentioned combination of infections.

EFFECT: higher efficiency of therapy.

1 dwg, 1 ex, 2 tbl